thiazoles has been researched along with amrubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isogawa, Y; Kakehi, Y; Kamoto, T; Kinoshita, H; Mizutani, Y; Ogawa, O; Terachi, T; Wu, XX | 1 |
| Hida, T; Horio, Y; Ogawa, S; Osada, H; Sekido, Y; Shimizu, J | 1 |
| Igishi, T; Kodani, M; Matsumoto, S; Matsunami, K; Morita, M; Nakazaki, H; Shigeoka, Y; Shimizu, E; Sumikawa, T; Suyama, H; Takeda, K; Ueda, Y | 1 |
3 other study(ies) available for thiazoles and amrubicin
| Article | Year |
|---|---|
Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.
Topics: Acridine Orange; Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Prostatic Neoplasms; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Biomarkers; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromosomal Instability; Coloring Agents; DNA Topoisomerases, Type II; Humans; Isoenzymes; Lung Neoplasms; Molecular Chaperones; Nuclear Pore Complex Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles | 2010 |
Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.
Topics: Anthracyclines; Benzamides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Imatinib Mesylate; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles | 2010 |